PerkinElmer maintained by Merrill at buy

PerkinElmer, Inc. was maintained by Merrill Lynch analyst J. Darryl Pardi at a buy rating after the company provided its outlook for 2006 earnings per share of $1.20 to $1.25, excluding $0.05 to $0.07 of option expense. Merrill expected option expense of $0.09, so it's raising earnings per share by $0.02. Organic revenue growth of 5% still is forecast. Better-than-expected growth in Genetic Screening and Biopharma could lead to the high end of management's outlook, Merrill said. Shares of the Wellesley, Mass., maker of scientific instruments were up 10 cents, or $23.04 on volume of 1,773,200 shares versus the three-month running average of 741,757 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.